MOH:NYSEMolina Healthcare Inc Analysis

Technical outlook: Molina Healthcare is trading at $149.2, well below its 200‑day SMA of $185.7 and the 50‑day SMA of $164.2, indicating a bearish price environment. The 30‑day volatility is exceptionally high at ~99% and the RSI sits near 48, suggesting no strong momentum, while the MACD histogram is positive but the overall trend is classified as bearish. Volume is decreasing and beta is near zero, implying limited price sensitivity to market moves but heightened idiosyncratic risk.
Fundamental backdrop: The company posted a surprise Q4 loss of $2.75 per share, missing guidance and triggering a 28% pre‑market drop. Revenue grew 7.1% YoY to $43.6 bn, yet operating margin is negative (-1.5%) and both operating and free cash flow are negative, raising concerns about cash generation. The balance sheet shows $8.3 bn in cash against $4.0 bn of debt (debt‑to‑equity ~99%). Valuation appears attractive with a PE of 16.7 versus the industry average of 26.2 and a price‑to‑book of 1.87, but the lack of dividend and regulatory pressure on Medicaid/Medicare payments add downside risk.